These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21889584)

  • 1. Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles.
    Ducat E; Deprez J; Gillet A; Noël A; Evrard B; Peulen O; Piel G
    Int J Pharm; 2011 Nov; 420(2):319-32. PubMed ID: 21889584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems.
    Keller M; Harbottle RP; Perouzel E; Colin M; Shah I; Rahim A; Vaysse L; Bergau A; Moritz S; Brahimi-Horn C; Coutelle C; Miller AD
    Chembiochem; 2003 Apr; 4(4):286-98. PubMed ID: 12672108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
    Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
    J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and intracellular release kinetics of liposome formulations in glioma cells.
    Bellavance MA; Poirier MB; Fortin D
    Int J Pharm; 2010 Aug; 395(1-2):251-9. PubMed ID: 20573571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units.
    Momekova D; Rangelov S; Yanev S; Nikolova E; Konstantinov S; Romberg B; Storm G; Lambov N
    Eur J Pharm Sci; 2007 Dec; 32(4-5):308-17. PubMed ID: 17928206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood.
    Ishida T; Okada Y; Kobayashi T; Kiwada H
    Int J Pharm; 2006 Feb; 309(1-2):94-100. PubMed ID: 16364578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the antiproliferative effect of rapamycin on tumor cell lines by poly (monomethylitaconate)-based pH-sensitive, plasma stable liposomes.
    Ghanbarzadeh S; Arami S; Pourmoazzen Z; Khorrami A
    Colloids Surf B Biointerfaces; 2014 Mar; 115():323-30. PubMed ID: 24394948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
    Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
    Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding.
    Nie Y; Günther M; Gu Z; Wagner E
    Biomaterials; 2011 Jan; 32(3):858-69. PubMed ID: 21030074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives.
    Xu H; Deng Y; Chen D; Hong W; Lu Y; Dong X
    J Control Release; 2008 Sep; 130(3):238-45. PubMed ID: 18657874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol.
    Lu XY; Hu S; Jin Y; Qiu LY
    Drug Dev Ind Pharm; 2012 Mar; 38(3):314-22. PubMed ID: 21851312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
    Qiu L; Jing N; Jin Y
    Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusogenic activity of PEGylated pH-sensitive liposomes.
    Vanić Z; Barnert S; Süss R; Schubert R
    J Liposome Res; 2012 Jun; 22(2):148-57. PubMed ID: 22149717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
    Maitani Y; Igarashi S; Sato M; Hattori Y
    Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes.
    Tu Y; Kim JS
    J Gene Med; 2008 Jun; 10(6):646-54. PubMed ID: 18383507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonspecific delivery of substances into pancreatic islet cells by pH-sensitive liposomes in vitro.
    Oberg C; Welsh N
    Diabete Metab; 1990; 16(1):48-54. PubMed ID: 2185056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.